The relationship between preoperative creatinine clearance and outcomes for patients undergoing liver transplantation: a retrospective observational study

BMC Nephrology

Markus Béchir²  Peter Steiger²  Silvia R Cottini²  Reto A Schuepbach²  Marcel Scherrer²  Paul A Stehberger²  Manuel Zimmermann²  Christian E Oberkofler¹  Thomas A Neff²  Urs Wenger² 

[1] Department of Visceral- and Transplantation Surgery, University Hospital of Zurich, Zurich, Switzerland;Surgical Intensive Care Medicine, University Hospital of Zurich, Raemistrasse 100, Zurich, CH 8091, Switzerland

关键词: Liver transplantation;    Renal replacement therapy;    Acute on chronic renal failure;    Acute renal failure;   

Others  :  1083001
DOI  :  10.1186/1471-2369-14-37

 received in 2012-09-05, accepted in 2013-02-13,  发布年份 2013

【 摘 要 】

Background

Renal failure with following continuous renal replacement therapy is a major clinical problem in liver transplant recipients, with reported incidences of 3% to 20%. Little is known about the significance of postoperative acute renal failure or acute-on-chronic renal failure to postoperative outcome in liver transplant recipients.

Methods

In this post hoc analysis we compared the mortality rates of 135 consecutive liver transplant recipients over 6 years in our center subject to their renal baseline conditions and postoperative RRT. We classified the patients into 4 groups, according to their preoperative calculated Cockcroft formula and the incidence of postoperative renal replacement therapy. Data then were analyzed in regard to mortality rates and in addition to pre- and peritransplant risk factors.

Results

There was a significant difference in ICU mortality (p=.008), hospital mortality (p=.002) and cumulative survival (p<.0001) between the groups. The highest mortality rate occurred in the group with RRT and normal baseline kidney function (20% ICU mortality, 26.6% hospital mortality and 50% cumulative 1-year mortality, respectively). The hazard ratio in this group was 9.6 (CI 3.2-28.6, p=.0001).

Conclusion

This study shows that in liver transplant recipient’s acute renal failure with postoperative RRT is associated with mortality and the mortality rate is higher than in patients with acute-on-chronic renal failure and postoperative renal replacement therapy.

【 授权许可】

   
2013 Wenger et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Chang T-J: Prognostic factors of postoperative ARF. Dial Transplatation 1999, 14(8):1850-1852.
• [2]Faenza S, Santoro A, Mancini E, Pareschi S, Siniscalchi A, Zanzani C, Pinna AD: Acute renal failure requiring renal replacement therapy after orthotopic liver transplantation. Transplant Proc 2006, 38(4):1141-1142.
• [3]Fraley DS, Burr R, Bernardini J, Angus D, Kramer DJ, Johnson JP: Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney Int 1998, 54(2):518-524.
• [4]Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, et al.: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294(7):813-818.
• [5]Cabezuelo JB, Ramirez P, Acosta F, Sanchez Bueno F, Robles R, Pons JA, Miras M, Munitiz V, Fernandez JA, Lujan J, et al.: Prognostic factors of early acute renal failure in liver transplantation. Transplant Proc 2002, 34(1):254-255.
• [6]de Mendonca A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M, Takala J, Sprung C, Cantraine F: Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000, 26(7):915-921.
• [7]Faenza S, Bernardi E, Cimatti M, Dante A, Mancini E, Miklosova Z, Piraccini E, Pierucci E, Riganello I, Spedicato S, et al.: Acute renal failure after liver transplantation in MELD era. Transplant Proc 2007, 39(6):1945-1946.
• [8]Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N: Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant 2006, 6(11):2651-2659.
• [9]Gonwa TA, Morris CA, Goldstein RM, Husberg BS, Klintmalm GB: Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome–experience in 300 patients. Transplantation 1991, 51(2):428-430.
• [10]Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS: Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995, 59(3):361-365.
• [11]Lo CM, Fan ST, Liu CL, Yong BH, Wong Y, Lau GK, Lai CL, Ng IO, Wong J: Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg 2004, 240(1):151-158.
• [12]Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F: Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. Dig Liver Dis 2009, 41(5):350-356.
• [13]Fabrizi F, Dixit V, Martin P, Messa P: Pre-transplant kidney function predicts chronic kidney disease after liver transplant: meta-analysis of observational studies. Dig Dis Sci 2011, 56(5):1282-1289.
• [14]Herlenius G, Fistouris J, Olausson M, Felldin M, Backman L, Friman S: Early renal function post-liver transplantation is predictive of progressive chronic kidney disease. Scand J Gastroenterol 2008, 43(3):344-349.
• [15]Ruiz R, Barri YM, Jennings LW, Chinnakotla S, Goldstein RM, Levy MF, McKenna GJ, Randall HB, Sanchez EQ, Klintmalm GB: Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT). Liver Transpl 2007, 13(6):838-843.
• [16]Rueggeberg A, Boehm S, Napieralski F, Mueller AR, Neuhaus P, Falke KJ, Gerlach H: Development of a risk stratification model for predicting acute renal failure in orthotopic liver transplantation recipients. Anaesthesia 2008, 63(11):1174-1180.
• [17]Shaw BW Jr, Martin DJ, Marquez JM, Kang YG, Bugbee AC Jr, Iwatsuki S, Griffith BP, Hardesty RL, Bahnson HT, Starzl TE: Venous bypass in clinical liver transplantation. Ann Surg 1984, 200(4):524-534.
• [18]Morard I, Mentha G, Spahr L, Majno P, Hadengue A, Huber O, Morel P, Giostra E: Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels. Clin Transplant 2006, 20(1):96-101.
• [19]Rognant N, Bacchetta J, Dubourg L, Ahmed SN, Radenne S, Dumortier J, Hadj-Aissa A: What is the best alternative to inulin clearance to estimate GFR in patients with decompensated alcoholic cirrhosis? Nephrol Dial Transplant 2010, 25(11):3569-3575.
• [20]Martin AP, Bartels M, Hauss J, Fangmann J: Overview of the MELD score and the UNOS adult liver allocation system. Transplant Proc 2007, 39(10):3169-3174.
• [21]Laws and regulations. http://www.Swisstransplant.org
• [22]McCormack L, Selzner M, Clavien P-A: The transplant operation. In Medical Care of Liver Transplantation. Edited by Killenberg P, Clavien P-A. Oxford, England: Blackwell Publishing; 2006:229-241.
• [23]Adam R, Bismuth H, Diamond T, Ducot B, Morino M, Astarcioglu I, Johann M, Azoulay D, Chiche L, Bao YM, et al.: Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet 1992, 340(8832):1373-1376.
• [24]Merion RM, Goodrich NP, Feng S: How can we define expanded criteria for liver donors? J Hepatol 2006, 45(4):484-488.
• [25]Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al.: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327.
• [26]Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149(3 Pt 1):818-824.
• [27]Sezer S, Karakan S, Erismis B, Colak T, Haberal M: Risk factors for kidney impairment and differential impact of liver transplantation on renal function. Transplant Proc 2011, 43(2):609-611.
• [28]Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB: Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004, 10(2):301-309.
• [29]Weismuller TJ, Prokein J, Becker T, Barg-Hock H, Klempnauer J, Manns MP, Strassburg CP: Prediction of survival after liver transplantation by pre-transplant parameters. Scand J Gastroenterol 2008, 43(6):736-746.
• [30]Oberkofler CE, Dutkowski P, Stocker R, Schuepbach RA, Stover JF, Clavien PA, Bechir M: Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients. Crit Care 2010, 14(3):R117. BioMed Central Full Text
• [31]Cherry T, Steciuk M, Reddy VV, Marques MB: Transfusion-related acute lung injury: past, present, and future. Am J Clin Pathol 2008, 129(2):287-297.
• [32]Klein HG, Spahn DR, Carson JL: Red blood cell transfusion in clinical practice. Lancet 2007, 370(9585):415-426.
• [33]Tinmouth A, Fergusson D, Yee IC, Hebert PC: Clinical consequences of red cell storage in the critically ill. Transfusion 2006, 46(11):2014-2027.
• [34]de Rougemont O, Dutkowski P, Weber M, Clavien P-A: Abdominal Drains in Liver Transplantation: Useful Tool or Useless Dogma? A match Case–control Study. Liver Transpl 2009, 15:96-101.
• [35]Nardo B, Bertelli R, Montalti R, Beltempo P, Puviani L, Pacile V, Cavallari A: Red blood cell transfusion in liver transplantation: a case–control study. Transplant Proc 2005, 37(10):4389-4392.
• [36]Gallardo M, Gutierrez M, Pérez G, Balsera E, Ortega J, Garcia G: Risk Factors for Renal Dysfunction in the Postoperative Course of Liver Transplant. Liver Transpl 2004, 10(11):1379-1385.
• [37]Massicotte L, Lenis S, Thibeault L, Sassine MP, Seal RF, Roy A: Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 2006, 12(1):117-123.
• [38]Mor E, Jennings L, Gonwa TA, Holman MJ, Gibbs J, Solomon H, Goldstein RM, Husberg BS, Watemberg IA, Klintmalm GB: The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet 1993, 176(3):219-227.
• [39]O'Riordan A, Wong V, McQuillan R, McCormick PA, Hegarty JE, Watson AJ: Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation. Am J Transplant 2007, 7(1):168-176.
• [40]Aggarwal S, Kang Y, Freeman JA, Fortunato FL Jr, Pinsky MR: Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J Crit Care 1993, 8(3):154-160.
• [41]Schroeder RA, Collins BH, Tuttle-Newhall E, Robertson K, Plotkin J, Johnson LB, Kuo PC: Intraoperative fluid management during orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2004, 18(4):438-441.
• [42]Izak G, Galewski K, Eyal Z: Studies on hypercoagulable state. II. The application of 131I-labelled fibrinogen for the estimation of intravascular coagulation in human subjects. Thromb Diath Haemorrh 1967, 18(3–4):544-551.
• [43]McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA: Use of severely steatotic grafts in liver transplantation: a matched case–control study. Ann Surg 2007, 246(6):940-946. discussion 946–948
• [44]Shaw BW Jr, Martin DJ, Marquez JM, Kang YG, Bugbee AC Jr, Iwatsuki S, Griffith BP, Hardesty RL, Bahnson HT, Starzl TE: Advantages of venous bypass during orthotopic transplantation of the liver. Semin Liver Dis 1985, 5(4):344-348.
• [45]Cabezuelo JB, Ramirez P, Acosta F, Torres D, Sansano T, Pons JA, Bru M, Montoya M, Rios A, Sanchez Bueno F, et al.: Does the standard vs piggyback surgical technique affect the development of early acute renal failure after orthotopic liver transplantation? Transplant Proc 2003, 35(5):1913-1914.
• [46]Tannuri U, Gibelli NE, Maksoud-Filho JG, Santos MM, Pinho-Apezzato ML, Velhote MC, Ayoub AA, Silva MM, Maksoud JG: Mycophenolate mofetil promotes prolonged improvement of renal dysfunction after pediatric liver transplantation: experience of a single center. Pediatr Transplant 2007, 11(1):82-86.
• [47]Watson CJ, Gimson AE, Alexander GJ, Allison ME, Gibbs P, Smith JC, Palmer CR, Bradley JA: A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl 2007, 13(12):1694-1702.